Cardiol Therapeutics Inc.
CRDL | NASDAQ
$1.90
+$0.04 (+2.15%)
Sep 22, 2026, 2:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | 62.27K | n/a |
Cost of Revenue | n/a | n/a | 187.38K | 162.23K | 174.26K | 180.17K |
Gross Profit | n/a | n/a | -187.38K | -162.23K | -112K | -180.17K |
Operating Income | -34.32M | -40.28M | -22.47M | -30.49M | -30.57M | -16.24M |
Interest Income | 726.4K | 1.19M | 2.04M | 1.24M | 106K | 60.11K |
Pretax Income | -33.82M | -36.68M | -21.22M | -22.82M | -25.01M | -16.2M |
Net Income | -33.82M | -36.68M | -21.22M | -22.82M | -25.01M | -16.2M |
Selling & General & Admin | 20.2M | 25.89M | 11.55M | 16.34M | 21.86M | 7.81M |
Research & Development | 14.02M | 14.01M | 10.73M | 13.99M | 8.59M | 8.25M |
Other Expenses | 101.98K | 373.11K | n/a | n/a | n/a | n/a |
Operating Expenses | 34.32M | 40.28M | 22.29M | 30.33M | 30.46M | 16.06M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 34.32M | 40.28M | 22.47M | 30.49M | 30.63M | 16.24M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 86.99M | 71.57M | 64.46M | 62.51M | 43.22M | 29.86M |
Shares Outstanding (Diluted) | 86.99M | 71.57M | 64.46M | 62.51M | 43.22M | 29.86M |
EPS (Basic) | -0.39 | -0.51 | -0.44 | -0.49 | -0.73 | -0.69 |
EPS (Diluted) | -0.39 | -0.51 | -0.44 | -0.49 | -0.73 | -0.69 |
EBITDA | -33.72M | -36.52M | -21.04M | -22.66M | -24.84M | -16.02M |
EBIT | -33.82M | -36.68M | -21.22M | -22.82M | -25.01M | -16.2M |
Depreciation & Amortization | 101.98K | 162.11K | 187.38K | 162.23K | 174.26K | 180.17K |
Add to Watchlist
Select watchlists to add or remove CRDL